06:47 AM EST, 02/24/2026 (MT Newswires) -- Elanco Animal Health ( ELAN ) reported Q4 adjusted earnings Tuesday of $0.13 per diluted share, down from $0.14 a year earlier.

Analysts polled by FactSet expected $0.11.

Revenue for the quarter ended Dec. 31 was $1.14 billion, compared with $1.02 billion a year earlier.

Analysts surveyed by FactSet expected $1.09 billion.

For Q1, the company expects adjusted EPS of between $0.33 to $0.36 on revenue of $1.28 billion to $1.31 billion. Analysts surveyed by FactSet are looking for adjusted EPS of $0.35 on revenue of $1.27 billion.

For 2026, the company expects adjusted EPS of $1 to $1.06 on revenue of $4.95 billion to $5.02 billion. Analysts surveyed by FactSet are looking for adjusted EPS of $1.03 on revenue of $4.93 billion.

Shares of the company were down 1.2% in recent Tuesday premarket activity.